Renal Cell Carcinoma: Clinical Management provides a comprehensive,
state-of-the art review of this field, and will serve as a valuable
resource for clinicians, surgeons and researchers with an interest in
kidney cancer. The volume reviews new data about risk factors for the
disease, profiles the new staging system for renal cell carcinoma (RCC),
highlights our current understanding of familial syndromes of RCC and
their molecular genetics, and provides new perspectives about imaging of
renal tumors. For localized disease, a greater appreciation of
nephron-sparing approaches and the importance of preservation of renal
function is discussed in detail. Advances in surgical techniques are
highlighted. For metastatic disease, the molecular biology of kidney
cancer is reviewed in a concise and understandable manner, including the
data that has fostered novel targeted approaches that have
revolutionized management. The several landmark phase III targeted
therapy trials published in the last few years are placed in context
with respect to current management. Integration of surgery and systemic
therapy through cytoreductive and consolidative approaches has yielded
provocative data that promises to further advance the field, and major
advances in this domain are also be discussed.